Se connecter Inscription gratuite

Adaptimmune Therapeutics Plc Revenu Y/Y

Quel est le Revenu Y/Y de Adaptimmune Therapeutics Plc?

Le Revenu Y/Y de Adaptimmune Therapeutics Plc est 99.90%

Quelle est la définition de Revenu Y/Y?

La croissance annuelle des revenus des trois dernières années correspond à la croissance moyenne des revenus d’une année sur l’autre au cours des trois dernières années.

The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.

Revenu Y/Y des entreprises dans Health Care secteur sur NASDAQ par rapport à Adaptimmune Therapeutics Plc

Que fait Adaptimmune Therapeutics Plc?

adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.

Entreprises avec revenu y/y similaire à Adaptimmune Therapeutics Plc